NORTH CHICAGO, Ill., Sept. 20, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization […]
